Haemoglobinopathies congenital Completed Phase 2 Trials for Busulfan (DB01008)

Also known as: Haemoglobinopathies / Haemoglobinopathy / Hemoglobinopathy / Hemoglobinopathies / Haemoglobinopathy NOS / Abnormal hemoglobin NOS

IndicationStatusPhase
DBCOND0026458 (Haemoglobinopathies congenital)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00153985Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With HemoglobinopathiesTreatment